Papers/PMID:16207291
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis.
Journal of pineal research2005The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Melatonin reduced the risk of death at 1 yr (relative risk: 0.66, 95% confidence interval: 0.59-0.73, I2=0%, heterogeneity P<or=0.56).”
Quoted verbatim from Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis.. - Study
- meta-analysis
- Population
- solid tumor cancer patients (10 RCTs, all conducted at the same hospital network, unblinded)
Effect 0.66 risk ratio, 95% CI 0.59 to 0.73
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis.2005PMID:16207291Permalink